Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Price to Earnings (2022)

Updated

Vitaspring Biomedical's (VSBC) Price to Earnings stood at 2500.61 in fiscal Q3 2023 (quarter ended Oct 31, 2022), down 9.9% from the prior quarter.

Analysis

Vitaspring Biomedical (VSBC) Price to Earnings (2022) Analysis & Trends

For FY2022 (ended Jan 31, 2022), Vitaspring Biomedical's Price to Earnings came in at 3178.77.

  • Per Business Quant, the preceding three fiscal quarters came in at 2776.58 (Q2 2023), 2764.62 (Q1 2023) and 2678.30 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Vitaspring Biomedical 2.07 Mn 2.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2022 2,500.61
Jul 31, 2022 2,776.58
Apr 30, 2022 2,764.62
Jan 31, 2022 2,678.30
API Access

Vitaspring Biomedical Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=VSBC&period=max&api_key=YOUR_API_KEY